Utah Medical Products Statistics Share Statistics Utah Medical Products has 3.25M
shares outstanding. The number of shares has increased by -6.58%
in one year.
Shares Outstanding 3.25M Shares Change (YoY) -6.58% Shares Change (QoQ) -1.02% Owned by Institutions (%) 67.44% Shares Floating 3.02M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 107.03K, so 3.29% of the outstanding
shares have been sold short.
Short Interest 107.03K Short % of Shares Out 3.29% Short % of Float 3.54% Short Ratio (days to cover) 6.88
Valuation Ratios The PE ratio is 15.52 and the forward
PE ratio is null.
Utah Medical Products's PEG ratio is
-1.16.
PE Ratio 15.52 Forward PE n/a PS Ratio 5.26 Forward PS n/a PB Ratio 1.83 P/FCF Ratio 14.75 PEG Ratio -1.16
Financial Ratio History Enterprise Valuation Utah Medical Products has an Enterprise Value (EV) of 132.64M.
EV / Sales 3.24 EV / EBITDA 8.07 EV / EBIT 8.94 EV / FCF 9.09
Financial Position The company has a current ratio of 25.64,
with a Debt / Equity ratio of 0.
Current Ratio 25.64 Quick Ratio 23.29 Debt / Equity 0 Debt / EBITDA 0.02 Debt / FCF 0.02 Interest Coverage 0
Financial Efficiency Return on Equity is 11.81% and Return on Invested Capital is 9.45%.
Return on Equity 11.81% Return on Assets 11.32% Return on Invested Capital 9.45% Revenue Per Employee $263.89K Profits Per Employee $89.51K Employee Count 155 Asset Turnover 0.33 Inventory Turnover 1.9
Taxes Income Tax 2.93M Effective Tax Rate 17.43%
Stock Price Statistics The stock price has increased by -16.14% in the
last 52 weeks. The beta is 0.32, so Utah Medical Products's
price volatility has been higher than the market average.
Beta 0.32 52-Week Price Change -16.14% 50-Day Moving Average 56.3 200-Day Moving Average 58.86 Relative Strength Index (RSI) 49.33 Average Volume (20 Days) 15,543
Income Statement In the last 12 months, Utah Medical Products had revenue of 40.9M
and earned 13.87M
in profits. Earnings per share was 3.96.
Revenue 40.9M Gross Profit 24.14M Operating Income 13.59M Net Income 13.87M EBITDA 16.44M EBIT 13.59M Earnings Per Share (EPS) 3.96
Full Income Statement Balance Sheet The company has 82.98M in cash and 282K in
debt, giving a net cash position of 82.69M.
Cash & Cash Equivalents 82.98M Total Debt 282K Net Cash 82.69M Retained Earnings 129.3M Total Assets 120.8M Working Capital 92.12M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 14.83M
and capital expenditures -235K, giving a free cash flow of 14.6M.
Operating Cash Flow 14.83M Capital Expenditures -235K Free Cash Flow 14.6M FCF Per Share 4.17
Full Cash Flow Statement Margins Gross margin is 59.03%, with operating and profit margins of 33.23% and 33.92%.
Gross Margin 59.03% Operating Margin 33.23% Pretax Margin 41.08% Profit Margin 33.92% EBITDA Margin 40.19% EBIT Margin 33.23% FCF Margin 35.68%
Dividends & Yields UTMD pays an annual dividend of $1.52,
which amounts to a dividend yield of 2.17%.
Dividend Per Share $1.52 Dividend Yield 2.17% Dividend Growth (YoY) 1.67% Payout Ratio 40.53% Earnings Yield 6.44% FCF Yield 6.78%
Dividend Details Analyst Forecast Currently there are no analyst rating for UTMD.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $24.04 Lynch Upside -56.89% Graham Number 54.66 Graham Upside -1.99%
Stock Splits The last stock split was on Mar 22, 1993. It was a
forward
split with a ratio of 3:2.
Last Split Date Mar 22, 1993 Split Type forward Split Ratio 3:2
Scores Altman Z-Score 35.2 Piotroski F-Score 6
